Yale epidemiologist Harvey Risch, who has entertained a connection between Covid vaccines and "turbo cancer" and promoted ivermectin, says he'll chair the President's Cancer Panel. An epidemiologist who has speculated about whether there is a connection between Covid-19 vaccines and "turbo cancer" in young people, and works as chief epidemiologist at a company that sells ivermectin alongside reviews that claim it has efficacy as a cancer treatment, has been appointed by president Donald Trump to a key position overseeing the National Cancer Program. Harvey Risch, a professor emeritus of epidemiology at the Yale School of Public Health, announced his appointment as chair of the President's Cancer Panel on X earlier this month. Risch's profile page on the Yale website has also been updated to read "In November 2025, President Trump appointed Dr. Risch to Chair the President's Cancer panel." No formal announcement was made by the president or the White House, and the Cancer Panel website's list of current members does not include Risch.

Understanding public discourse on emergency use of unproven therapeutics is crucial for monitoring safe use and combating misinformation. We developed a natural language processing-based pipeline to comprehend public perceptions of and stances on coronavirus disease 2019 (COVID-19)-related drugs on Twitter over time. This retrospective study included 609,189 US-based tweets from January 29, 2020, to November 30, 2021, about four drugs that garnered significant public attention during the COVID-19 pandemic: (1) Hydroxychloroquine and Ivermectin, therapies with anecdotal evidence; and (2) Molnupiravir and Remdesivir, FDA-approved treatments for eligible patients. Time-trend analysis was employed to understand popularity trends and related events. Content and demographic analyses were conducted to explore potential rationales behind people's stances on each drug. Time-trend analysis indicated that Hydroxychloroquine and Ivermectin were discussed more than Molnupiravir and Remdesivir, particularly during COVID-19 surges. Hydroxychloroquine and Ivermectin discussions were highly politicized, related to conspiracy theories, hearsay, and celebrity influences. The distribution of stances between the two major US political parties was significantly different (P < .001); Republicans were more likely to support Hydroxychloroquine (55%) and Ivermectin (30%) than Democrats. People with healthcare backgrounds tended to oppose Hydroxychloroquine (7%) more than the general population, while the general population was more likely to support Ivermectin (14%). Our study found that social media users have varying perceptions and stances on off-label versus FDA-authorized drug use at different stages of COVID-19. This indicates that health systems, regulatory agencies, and policymakers should design tailored strategies to monitor and reduce misinformation to promote safe drug use.

In media news today, Katie Couric admits she protected Ruth Bader Ginsburg by editing out remarks on anthem kneelers, a former Obama ethics official slams the Biden White House for avoiding questions on Hunter Biden's artwork, and Facebook says it will treat journalist and activists as public figures CNN chief medical correspondent Dr. Sanjay Gupta sought to explain the reasoning behind his appearance on Joe Rogan's podcast "The Joe Rogan Experience" this week, claiming he felt he "needed to go into the lion's den" to communicate to people about public health. Gupta faced intense criticism stemming from his appearance on the show, in which he admitted that CNN shouldn't have referred to Rogan's use of the drug ivermectin to treat the coronavirus as him using "horse dewormer." CNN did not immediately respond when asked if Gupta was forced to justify the appearance in his Wednesday piece following the backlash. In the piece titled "Why Joe Rogan and I sat down and talked -- for more than 3 hours," Gupta detailed his conversation with Rogan, including his "futile" attempt to convince the popular radio host to take the coronavirus vaccine, and compared it to being in a mixed martial arts (MMA) bout. "I realized that if I was serious about trying to communicate public health, I needed to go to a less comfortable place. I needed to go into the lion's den and accept an invitation to sit down with Joe Rogan for more than three hours," Gupta wrote before admitting that many of his friends advised him not to accept Rogan's invitation.